External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ESMO IO 2020

-
Coming soon
01:50 PM
Duration 12mins Virtual
Clinical Outcomes in Post-Operative ctDNA(+) Muscle-Invasive Urothelial Carcinoma Patients After Atezolizumabâ–¼ Adjuvant Therapy

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar